Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
2055 participants
INTERVENTIONAL
2015-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Physical Activity Incentives
NCT03037658
Incentivizing Planning & Output in Exercising
NCT03742765
A Test of Different Incentives and How Effectively They Motivate Walking Behaviour
NCT06395233
Incentivizing Reflection and Output in Exercise
NCT03742778
Creating Exercise Habits Through Incentives for Routines
NCT02346799
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In this experiment, the investigators will test the effectiveness of a two week 20x incentive multiplier on AchieveMint users who are (a) not notified about the incentives in advance, and (b) notified about the incentives and their purpose. The investigators will test which group shows the largest boost in walking during the two week intervention and the most lasting behavior change.
Information:
The experimental conditions will vary the type and amount of information about incentives as follows:
* Condition 1 - Uninformed: Users will receive 20x their usual incentives for two weeks, but will receive no emails informing them about the incentive program. (They may find out about incentives through the Achievemint platform.)
* Condition 2 - Informed about Incentives and Purpose: Users will receive 20x their usual incentives for two weeks, and they will receive emails informing them about the incentives (one announcement before the incentives begin, and one email every two days reminding them about the overall incentive program). These emails will contain information about the incentives and the purpose of the incentives. Condition 2 will most closely resemble the "constant" condition in the previous experiment. Roughly the same initial announcement email will go out. The reminder emails sent every two days, however, will include more information about the overall program incentives to maximize the number of participants who learn about the incentive program at some point.
Mock-ups of the email announcements and reminders are shown below.
Incentives:
The investigators' incentives will consist of multipliers for points offered via Achievemint. Since the investigators found in the investigators' last experiment that the constant incentives were the most successful, the investigators will offer these incentives to all treated participants: 20x multipliers for 14 days.
Other details:
The other details of the experiment will be the same as the previous experiment:
* Length of incentives: the investigators will offer incentives for 14 days.
* Post-intervention observation: the investigators will observe all treatment groups for at least 30 days after the intervention.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Uninformed
Condition 1
Uninformed
Users will receive 20x their usual incentives for two weeks, but will either receive no emails informing them about the incentive program.
Informed about Incentives and Purpose
Condition 2
Informed
Users will receive 20x their usual incentives for two weeks, and they will receive emails informing them about the incentives (one announcement before the incentives begin, and one email every two days reminding them about the overall incentive program). These emails will contain information about the incentives and the purpose of the incentives. The reminder emails sent every two days, however, will include more information about the overall program incentives to maximize the number of participants who learn about the incentive program at some point.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Uninformed
Users will receive 20x their usual incentives for two weeks, but will either receive no emails informing them about the incentive program.
Informed
Users will receive 20x their usual incentives for two weeks, and they will receive emails informing them about the incentives (one announcement before the incentives begin, and one email every two days reminding them about the overall incentive program). These emails will contain information about the incentives and the purpose of the incentives. The reminder emails sent every two days, however, will include more information about the overall program incentives to maximize the number of participants who learn about the incentive program at some point.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* To the extent possible, given the investigators' target sample size, the investigators will exclude users who were enrolled in the investigators' previous experiment.
18 Years
75 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Harvard University
OTHER
University of Pennsylvania
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Katherine L. Milkman, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
University of Pennsylvania
Bradford Tuckfield
Role: PRINCIPAL_INVESTIGATOR
University of Pennsylvania
Francesco Gino, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
HBS
Leslie K. John, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
HBS
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Pennsylvania
Philadelphia, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
819369
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.